0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global TYK2 Targeting Drugs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-24D18119
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global TYK2 Targeting Drugs Market Research Report 2024
BUY CHAPTERS

Global TYK2 Targeting Drugs Market Research Report 2024

Code: QYRE-Auto-24D18119
Report
October 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

TYK2 Targeting Drugs Market

TYK2 target drugs mainly target tyrosine kinase 2 (TYK2), which is a member of the JAK kinase family and plays a key role in inflammatory immune diseases by regulating specific cytokine signal transduction.
The global TYK2 Targeting Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for TYK2 Targeting Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for TYK2 Targeting Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of TYK2 Targeting Drugs include Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Qiyuan Biotechnology, Inventisbio, Changzhou Hengbang Pharmaceutical, Ventyx Biosciences, Galapagos NV, Oncostellae, BeiGene, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for TYK2 Targeting Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TYK2 Targeting Drugs.
The TYK2 Targeting Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global TYK2 Targeting Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TYK2 Targeting Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of TYK2 Targeting Drugs Market Report

Report Metric Details
Report Name TYK2 Targeting Drugs Market
Segment by Type
  • Single-target Inhibitors
  • Dual-target Inhibitors
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Qiyuan Biotechnology, Inventisbio, Changzhou Hengbang Pharmaceutical, Ventyx Biosciences, Galapagos NV, Oncostellae, BeiGene, Sareum Holdings Pic, Guangzhou Zaiji Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of TYK2 Targeting Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the TYK2 Targeting Drugs Market report?

Ans: The main players in the TYK2 Targeting Drugs Market are Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Qiyuan Biotechnology, Inventisbio, Changzhou Hengbang Pharmaceutical, Ventyx Biosciences, Galapagos NV, Oncostellae, BeiGene, Sareum Holdings Pic, Guangzhou Zaiji Pharmaceutical

What are the Application segmentation covered in the TYK2 Targeting Drugs Market report?

Ans: The Applications covered in the TYK2 Targeting Drugs Market report are Psoriasis, Systemic Lupus Erythematosus, Dermatitis, Arthritis, Others

What are the Type segmentation covered in the TYK2 Targeting Drugs Market report?

Ans: The Types covered in the TYK2 Targeting Drugs Market report are Single-target Inhibitors, Dual-target Inhibitors

Recommended Reports

Targeted Drug Therapy

Kinase Inhibitor Markets

Immunology & Oncology Drugs

1 TYK2 Targeting Drugs Market Overview
1.1 Product Definition
1.2 TYK2 Targeting Drugs by Type
1.2.1 Global TYK2 Targeting Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Single-target Inhibitors
1.2.3 Dual-target Inhibitors
1.3 TYK2 Targeting Drugs by Application
1.3.1 Global TYK2 Targeting Drugs Market Value by Application (2024-2030)
1.3.2 Psoriasis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Dermatitis
1.3.5 Arthritis
1.3.6 Others
1.4 Global TYK2 Targeting Drugs Market Size Estimates and Forecasts
1.4.1 Global TYK2 Targeting Drugs Revenue 2019-2030
1.4.2 Global TYK2 Targeting Drugs Sales 2019-2030
1.4.3 Global TYK2 Targeting Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 TYK2 Targeting Drugs Market Competition by Manufacturers
2.1 Global TYK2 Targeting Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global TYK2 Targeting Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global TYK2 Targeting Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of TYK2 Targeting Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of TYK2 Targeting Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TYK2 Targeting Drugs, Product Type & Application
2.7 Global Key Manufacturers of TYK2 Targeting Drugs, Date of Enter into This Industry
2.8 Global TYK2 Targeting Drugs Market Competitive Situation and Trends
2.8.1 Global TYK2 Targeting Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest TYK2 Targeting Drugs Players Market Share by Revenue
2.8.3 Global TYK2 Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global TYK2 Targeting Drugs Market Scenario by Region
3.1 Global TYK2 Targeting Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global TYK2 Targeting Drugs Sales by Region: 2019-2030
3.2.1 Global TYK2 Targeting Drugs Sales by Region: 2019-2024
3.2.2 Global TYK2 Targeting Drugs Sales by Region: 2025-2030
3.3 Global TYK2 Targeting Drugs Revenue by Region: 2019-2030
3.3.1 Global TYK2 Targeting Drugs Revenue by Region: 2019-2024
3.3.2 Global TYK2 Targeting Drugs Revenue by Region: 2025-2030
3.4 North America TYK2 Targeting Drugs Market Facts & Figures by Country
3.4.1 North America TYK2 Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America TYK2 Targeting Drugs Sales by Country (2019-2030)
3.4.3 North America TYK2 Targeting Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe TYK2 Targeting Drugs Market Facts & Figures by Country
3.5.1 Europe TYK2 Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe TYK2 Targeting Drugs Sales by Country (2019-2030)
3.5.3 Europe TYK2 Targeting Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TYK2 Targeting Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific TYK2 Targeting Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific TYK2 Targeting Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific TYK2 Targeting Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America TYK2 Targeting Drugs Market Facts & Figures by Country
3.7.1 Latin America TYK2 Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America TYK2 Targeting Drugs Sales by Country (2019-2030)
3.7.3 Latin America TYK2 Targeting Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa TYK2 Targeting Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa TYK2 Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa TYK2 Targeting Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa TYK2 Targeting Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TYK2 Targeting Drugs Sales by Type (2019-2030)
4.1.1 Global TYK2 Targeting Drugs Sales by Type (2019-2024)
4.1.2 Global TYK2 Targeting Drugs Sales by Type (2025-2030)
4.1.3 Global TYK2 Targeting Drugs Sales Market Share by Type (2019-2030)
4.2 Global TYK2 Targeting Drugs Revenue by Type (2019-2030)
4.2.1 Global TYK2 Targeting Drugs Revenue by Type (2019-2024)
4.2.2 Global TYK2 Targeting Drugs Revenue by Type (2025-2030)
4.2.3 Global TYK2 Targeting Drugs Revenue Market Share by Type (2019-2030)
4.3 Global TYK2 Targeting Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global TYK2 Targeting Drugs Sales by Application (2019-2030)
5.1.1 Global TYK2 Targeting Drugs Sales by Application (2019-2024)
5.1.2 Global TYK2 Targeting Drugs Sales by Application (2025-2030)
5.1.3 Global TYK2 Targeting Drugs Sales Market Share by Application (2019-2030)
5.2 Global TYK2 Targeting Drugs Revenue by Application (2019-2030)
5.2.1 Global TYK2 Targeting Drugs Revenue by Application (2019-2024)
5.2.2 Global TYK2 Targeting Drugs Revenue by Application (2025-2030)
5.2.3 Global TYK2 Targeting Drugs Revenue Market Share by Application (2019-2030)
5.3 Global TYK2 Targeting Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 InnoCare
6.2.1 InnoCare Company Information
6.2.2 InnoCare Description and Business Overview
6.2.3 InnoCare TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 InnoCare TYK2 Targeting Drugs Product Portfolio
6.2.5 InnoCare Recent Developments/Updates
6.3 Takeda (Nimbus Therapeutics)
6.3.1 Takeda (Nimbus Therapeutics) Company Information
6.3.2 Takeda (Nimbus Therapeutics) Description and Business Overview
6.3.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
6.3.5 Takeda (Nimbus Therapeutics) Recent Developments/Updates
6.4 Qiyuan Biotechnology
6.4.1 Qiyuan Biotechnology Company Information
6.4.2 Qiyuan Biotechnology Description and Business Overview
6.4.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
6.4.5 Qiyuan Biotechnology Recent Developments/Updates
6.5 Inventisbio
6.5.1 Inventisbio Company Information
6.5.2 Inventisbio Description and Business Overview
6.5.3 Inventisbio TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
6.5.5 Inventisbio Recent Developments/Updates
6.6 Changzhou Hengbang Pharmaceutical
6.6.1 Changzhou Hengbang Pharmaceutical Company Information
6.6.2 Changzhou Hengbang Pharmaceutical Description and Business Overview
6.6.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
6.6.5 Changzhou Hengbang Pharmaceutical Recent Developments/Updates
6.7 Ventyx Biosciences
6.7.1 Ventyx Biosciences Company Information
6.7.2 Ventyx Biosciences Description and Business Overview
6.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
6.7.5 Ventyx Biosciences Recent Developments/Updates
6.8 Galapagos NV
6.8.1 Galapagos NV Company Information
6.8.2 Galapagos NV Description and Business Overview
6.8.3 Galapagos NV TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
6.8.5 Galapagos NV Recent Developments/Updates
6.9 Oncostellae
6.9.1 Oncostellae Company Information
6.9.2 Oncostellae Description and Business Overview
6.9.3 Oncostellae TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
6.9.5 Oncostellae Recent Developments/Updates
6.10 BeiGene
6.10.1 BeiGene Company Information
6.10.2 BeiGene Description and Business Overview
6.10.3 BeiGene TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BeiGene TYK2 Targeting Drugs Product Portfolio
6.10.5 BeiGene Recent Developments/Updates
6.11 Sareum Holdings Pic
6.11.1 Sareum Holdings Pic Company Information
6.11.2 Sareum Holdings Pic Description and Business Overview
6.11.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
6.11.5 Sareum Holdings Pic Recent Developments/Updates
6.12 Guangzhou Zaiji Pharmaceutical
6.12.1 Guangzhou Zaiji Pharmaceutical Company Information
6.12.2 Guangzhou Zaiji Pharmaceutical Description and Business Overview
6.12.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
6.12.5 Guangzhou Zaiji Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TYK2 Targeting Drugs Industry Chain Analysis
7.2 TYK2 Targeting Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TYK2 Targeting Drugs Production Mode & Process
7.4 TYK2 Targeting Drugs Sales and Marketing
7.4.1 TYK2 Targeting Drugs Sales Channels
7.4.2 TYK2 Targeting Drugs Distributors
7.5 TYK2 Targeting Drugs Customers
8 TYK2 Targeting Drugs Market Dynamics
8.1 TYK2 Targeting Drugs Industry Trends
8.2 TYK2 Targeting Drugs Market Drivers
8.3 TYK2 Targeting Drugs Market Challenges
8.4 TYK2 Targeting Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global TYK2 Targeting Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global TYK2 Targeting Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global TYK2 Targeting Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global TYK2 Targeting Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global TYK2 Targeting Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global TYK2 Targeting Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global TYK2 Targeting Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market TYK2 Targeting Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of TYK2 Targeting Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of TYK2 Targeting Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of TYK2 Targeting Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of TYK2 Targeting Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global TYK2 Targeting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TYK2 Targeting Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global TYK2 Targeting Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global TYK2 Targeting Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global TYK2 Targeting Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global TYK2 Targeting Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global TYK2 Targeting Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global TYK2 Targeting Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global TYK2 Targeting Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global TYK2 Targeting Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global TYK2 Targeting Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America TYK2 Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America TYK2 Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America TYK2 Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America TYK2 Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America TYK2 Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe TYK2 Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe TYK2 Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe TYK2 Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe TYK2 Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe TYK2 Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific TYK2 Targeting Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific TYK2 Targeting Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific TYK2 Targeting Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific TYK2 Targeting Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific TYK2 Targeting Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America TYK2 Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America TYK2 Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America TYK2 Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America TYK2 Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America TYK2 Targeting Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa TYK2 Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa TYK2 Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa TYK2 Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa TYK2 Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa TYK2 Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global TYK2 Targeting Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global TYK2 Targeting Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global TYK2 Targeting Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global TYK2 Targeting Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global TYK2 Targeting Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global TYK2 Targeting Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global TYK2 Targeting Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global TYK2 Targeting Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global TYK2 Targeting Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global TYK2 Targeting Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global TYK2 Targeting Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global TYK2 Targeting Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global TYK2 Targeting Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global TYK2 Targeting Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global TYK2 Targeting Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global TYK2 Targeting Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Bristol Myers Squibb Company Information
 Table 71. Bristol Myers Squibb Description and Business Overview
 Table 72. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Bristol Myers Squibb TYK2 Targeting Drugs Product
 Table 74. Bristol Myers Squibb Recent Developments/Updates
 Table 75. InnoCare Company Information
 Table 76. InnoCare Description and Business Overview
 Table 77. InnoCare TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. InnoCare TYK2 Targeting Drugs Product
 Table 79. InnoCare Recent Developments/Updates
 Table 80. Takeda (Nimbus Therapeutics) Company Information
 Table 81. Takeda (Nimbus Therapeutics) Description and Business Overview
 Table 82. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product
 Table 84. Takeda (Nimbus Therapeutics) Recent Developments/Updates
 Table 85. Qiyuan Biotechnology Company Information
 Table 86. Qiyuan Biotechnology Description and Business Overview
 Table 87. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Qiyuan Biotechnology TYK2 Targeting Drugs Product
 Table 89. Qiyuan Biotechnology Recent Developments/Updates
 Table 90. Inventisbio Company Information
 Table 91. Inventisbio Description and Business Overview
 Table 92. Inventisbio TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Inventisbio TYK2 Targeting Drugs Product
 Table 94. Inventisbio Recent Developments/Updates
 Table 95. Changzhou Hengbang Pharmaceutical Company Information
 Table 96. Changzhou Hengbang Pharmaceutical Description and Business Overview
 Table 97. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product
 Table 99. Changzhou Hengbang Pharmaceutical Recent Developments/Updates
 Table 100. Ventyx Biosciences Company Information
 Table 101. Ventyx Biosciences Description and Business Overview
 Table 102. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Ventyx Biosciences TYK2 Targeting Drugs Product
 Table 104. Ventyx Biosciences Recent Developments/Updates
 Table 105. Galapagos NV Company Information
 Table 106. Galapagos NV Description and Business Overview
 Table 107. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Galapagos NV TYK2 Targeting Drugs Product
 Table 109. Galapagos NV Recent Developments/Updates
 Table 110. Oncostellae Company Information
 Table 111. Oncostellae Description and Business Overview
 Table 112. Oncostellae TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Oncostellae TYK2 Targeting Drugs Product
 Table 114. Oncostellae Recent Developments/Updates
 Table 115. BeiGene Company Information
 Table 116. BeiGene Description and Business Overview
 Table 117. BeiGene TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. BeiGene TYK2 Targeting Drugs Product
 Table 119. BeiGene Recent Developments/Updates
 Table 120. Sareum Holdings Pic Company Information
 Table 121. Sareum Holdings Pic Description and Business Overview
 Table 122. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Sareum Holdings Pic TYK2 Targeting Drugs Product
 Table 124. Sareum Holdings Pic Recent Developments/Updates
 Table 125. Guangzhou Zaiji Pharmaceutical Company Information
 Table 126. Guangzhou Zaiji Pharmaceutical Description and Business Overview
 Table 127. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product
 Table 129. Guangzhou Zaiji Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. TYK2 Targeting Drugs Distributors List
 Table 133. TYK2 Targeting Drugs Customers List
 Table 134. TYK2 Targeting Drugs Market Trends
 Table 135. TYK2 Targeting Drugs Market Drivers
 Table 136. TYK2 Targeting Drugs Market Challenges
 Table 137. TYK2 Targeting Drugs Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of TYK2 Targeting Drugs
 Figure 2. Global TYK2 Targeting Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global TYK2 Targeting Drugs Market Share by Type: 2023 & 2030
 Figure 4. Single-target Inhibitors Product Picture
 Figure 5. Dual-target Inhibitors Product Picture
 Figure 6. Global TYK2 Targeting Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global TYK2 Targeting Drugs Market Share by Application: 2023 & 2030
 Figure 8. Psoriasis
 Figure 9. Systemic Lupus Erythematosus
 Figure 10. Dermatitis
 Figure 11. Arthritis
 Figure 12. Others
 Figure 13. Global TYK2 Targeting Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global TYK2 Targeting Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global TYK2 Targeting Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global TYK2 Targeting Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. TYK2 Targeting Drugs Report Years Considered
 Figure 18. TYK2 Targeting Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global TYK2 Targeting Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest TYK2 Targeting Drugs Players: Market Share by Revenue in TYK2 Targeting Drugs in 2023
 Figure 21. TYK2 Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global TYK2 Targeting Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America TYK2 Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America TYK2 Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe TYK2 Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe TYK2 Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific TYK2 Targeting Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific TYK2 Targeting Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America TYK2 Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa TYK2 Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa TYK2 Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE TYK2 Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of TYK2 Targeting Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of TYK2 Targeting Drugs by Type (2019-2030)
 Figure 55. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of TYK2 Targeting Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of TYK2 Targeting Drugs by Application (2019-2030)
 Figure 58. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. TYK2 Targeting Drugs Value Chain
 Figure 60. TYK2 Targeting Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension